Phreesia (PHR) Projected to Post Quarterly Earnings on Thursday

Key Points

• Phreesia is set to announce its Q2 2026 earnings on September 4th, with analysts predicting a loss of ($0.07) per share and revenues of $116.39 million.
• In its last earnings report, Phreesia exceeded expectations, reporting a loss of ($0.07) per share, better than the estimated ($0.13), and revenues of $115.94 million.
• The stock has received multiple upgrades, including a "strong-buy" rating from DA Davidson and a raised price target from Truist Financial to $35.00.

Phreesia (NYSE:PHR - Get Free Report) is anticipated to announce its Q2 2026 results after the market closes on Thursday, September 4th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $116.39 million for the quarter. Investors are encouraged to explore the company's upcoming Q2 2026 earningoverview page for the latest details on the call scheduled for Thursday, September 4, 2025 at 5:00 PM ET.

Phreesia Trading Down 0.6%

Shares of PHR stock traded down $0.20 during trading hours on Tuesday, reaching $31.47. The company's stock had a trading volume of 829,881 shares, compared to its average volume of 757,878. The stock has a market capitalization of $1.87 billion, a P/E ratio of -42.52 and a beta of 0.72. Phreesia has a one year low of $17.07 and a one year high of $32.76. The firm's fifty day simple moving average is $28.22 and its 200 day simple moving average is $26.52. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on PHR shares. Mizuho started coverage on Phreesia in a research report on Wednesday, August 27th. They issued an "outperform" rating and a $36.00 price objective on the stock. Canaccord Genuity Group cut their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research report on Thursday, May 29th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Citigroup reiterated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Finally, KeyCorp lifted their price objective on Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating and eleven have assigned a Buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $32.58.

Insider Transactions at Phreesia

In other Phreesia news, insider David Linetsky sold 17,445 shares of the company's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $29.73, for a total value of $518,639.85. Following the sale, the insider owned 174,002 shares in the company, valued at approximately $5,173,079.46. This represents a 9.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 1,245 shares of the firm's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $33,478.05. Following the transaction, the general counsel directly owned 136,978 shares of the company's stock, valued at $3,683,338.42. This represents a 0.90% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 119,874 shares of company stock worth $3,587,618. 5.50% of the stock is owned by insiders.

Institutional Trading of Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Tower Research Capital LLC TRC increased its position in Phreesia by 332.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,610 shares of the company's stock valued at $160,000 after buying an additional 4,313 shares in the last quarter. Globeflex Capital L P raised its stake in Phreesia by 62.3% during the second quarter. Globeflex Capital L P now owns 10,070 shares of the company's stock valued at $287,000 after buying an additional 3,866 shares during the last quarter. Prudential Financial Inc. purchased a new position in Phreesia during the second quarter valued at $298,000. Caxton Associates LLP purchased a new position in Phreesia during the first quarter valued at $316,000. Finally, State of Tennessee Department of Treasury purchased a new position in Phreesia during the second quarter valued at $330,000. Hedge funds and other institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.